ProMIS Neurosciences, Inc. (PMN)
13.07
-0.90
(-6.48%)
USD |
NASDAQ |
Sep 03, 16:00
13.07
0.00 (0.00%)
After-Hours: 20:00
ProMIS Neurosciences Shareholders Equity (Quarterly) : 49.40M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 49.40M |
| March 31, 2026 | 60.72M |
| December 31, 2025 | -1.259M |
| September 30, 2025 | 9.187M |
| June 30, 2025 | -0.3826M |
| March 31, 2025 | 9.472M |
| December 31, 2024 | 16.49M |
| September 30, 2024 | 7.273M |
| June 30, 2024 | -2.277M |
| March 31, 2024 | 0.0771M |
| December 31, 2023 | 3.753M |
| September 30, 2023 | 6.755M |
| June 30, 2023 | -8.528M |
| March 31, 2023 | -6.179M |
| December 31, 2022 | -1.348M |
| September 30, 2022 | 0.7298M |
| June 30, 2022 | 6.710M |
| March 31, 2022 | 3.737M |
| December 31, 2021 | 5.919M |
| September 30, 2021 | 7.596M |
| June 30, 2021 | -7.107M |
| March 31, 2021 | -6.909M |
| December 31, 2020 | -0.7974M |
| September 30, 2020 | -1.529M |
| June 30, 2020 | -0.3892M |
| Date | Value |
|---|---|
| March 31, 2020 | -0.1361M |
| December 31, 2019 | 0.307M |
| September 30, 2019 | -0.7249M |
| June 30, 2019 | 0.417M |
| March 31, 2019 | 0.8669M |
| December 31, 2018 | 0.8466M |
| September 30, 2018 | 3.441M |
| June 30, 2018 | 5.146M |
| March 31, 2018 | 1.437M |
| December 31, 2017 | 1.224M |
| September 30, 2017 | 2.078M |
| June 30, 2017 | -0.0586M |
| March 31, 2017 | 1.237M |
| December 31, 2016 | 0.0518M |
| September 30, 2016 | 0.8336M |
| June 30, 2016 | 0.295M |
| March 31, 2016 | 0.484M |
| December 31, 2015 | 0.4319M |
| September 30, 2015 | 0.819M |
| June 30, 2015 | -0.7154M |
| March 31, 2015 | -0.494M |
| December 31, 2014 | -0.1711M |
| September 30, 2014 | -0.0735M |
| June 30, 2014 | 0.4034M |
| March 31, 2014 |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Edesa Biotech, Inc. | 8.811M |
| Arrowhead Pharmaceuticals, Inc. | 465.53M |
| Oncolytics Biotech, Inc. | -6.167M |
| Sangamo Therapeutics, Inc. | -18.96M |
| Sarepta Therapeutics, Inc. | 1.528B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 56.69M |
| Total Liabilities (Quarterly) | 7.295M |
| Current Ratio | 7.855 |